The FDA issued warning letters to two international drug manufacturers for breaching GMP standards by failing to develop procedures to maintain the appropriate quality controls.
Source: International Pharmaceutical Regulatory Monitor
The FDA issued warning letters to two international drug manufacturers for breaching GMP standards by failing to develop procedures to maintain the appropriate quality controls.
Source: International Pharmaceutical Regulatory Monitor